Stocks in play: Appili Therapeutics Inc.
Has entered into a definitive agreement with respect to an unsecured $300,000 bridge loan from Bloom Burton & Co. Inc. Appili Therapeutics Inc. shares T.APLI are trading unchanged at $0.04.
Read:
Novel Mechanisms Leading the Charge in Fight Against Cancer, Opening Door to New Drugs & Therapies
Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023
Promising New Cancer Treatment Data to Be Presented at 2023 ASCO Annual Meeting
Global Lithium Supply Under Pressure as South American Nations Discuss "Lithium OPEC"